A detailed history of Schonfeld Strategic Advisors LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 164,013 shares of VRDN stock, worth $1.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
164,013
Previous 178,919 8.33%
Holding current value
$1.99 Million
Previous $3.9 Million 26.31%
% of portfolio
0.02%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.09 - $23.82 $254,743 - $355,060
-14,906 Reduced 8.33%
164,013 $2.87 Million
Q4 2023

Feb 14, 2024

BUY
$11.12 - $22.5 $788,207 - $1.59 Million
70,882 Added 65.61%
178,919 $3.9 Million
Q3 2023

Nov 14, 2023

BUY
$15.16 - $24.7 $1.28 Million - $2.09 Million
84,670 Added 362.35%
108,037 $1.66 Million
Q2 2023

Aug 14, 2023

BUY
$22.57 - $29.67 $527,393 - $693,298
23,367 New
23,367 $555,000
Q4 2022

Feb 14, 2023

SELL
$18.78 - $29.74 $398,567 - $631,172
-21,223 Reduced 40.33%
31,400 $917,000
Q3 2022

Nov 14, 2022

BUY
$10.7 - $25.5 $563,066 - $1.34 Million
52,623 New
52,623 $945,000
Q1 2022

May 16, 2022

SELL
$16.79 - $20.88 $361,186 - $449,170
-21,512 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$15.65 - $21.5 $351,937 - $483,492
-22,488 Reduced 51.11%
21,512 $425,000
Q3 2021

Nov 16, 2021

BUY
$10.69 - $18.2 $470,360 - $800,800
44,000 New
44,000 $724,000

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $485M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.